Document is current
Any future updates will be listed below
-
Authors
Ankeny, Sarrah E.
Bacci, Julia R.
Decourt, Boris
Sabbagh, Marwan N.
Mielke, Michelle M. https://orcid.org/0000-0001-7177-1185
-
Funding
Funding for this research was provided by:
National Institute on Aging (U24 AG082930, RF1 AG077386, RF1 AG079397, RF1 AG69052, P30 AG07247, R01 AG059008, R01 AG073212)
National Institute of Neurological Disorders and Stroke (T32 NS115704)
Lewy Body Dementia Association (LBDA1811MS)
- License Information
-
More Information
Article History
Received: 2 June 2024
Accepted: 20 August 2024
First Online: 7 September 2024
Declarations
:
: Dr. Mielke has served on scientific advisory boards and/or has consulted for Acadia, Biogen, Eisai, LabCorp, Lilly, Merck, PeerView Institute, Novo Nordisk, Roche, Siemens Healthineers and Sunbird Bio. Dr. Sabbagh is an Editor-in-Chief of <i>Neurology and Therapy</i>. Dr. Sabbagh was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dr. Sabbagh has served as the Board of Directors for EIP Pharma/CervoMed and consulted for Roche-Genentech, Eisai, Lilly, NeuroTherapia, Signant Health, Novo Nordisk, Anavex, Cognito Therapeutics, GSK, Abbvie, Lighthouse Pharmaceuticals, Alzheon, and Athira. All other authors report no conflicts of interest.
: This review is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
